Eutilex.Co.Ltd Total Liabilities

Latest as of September 2025: ₩22.09 Billion KRW ≈ $14.97 Million USD

Eutilex.Co.Ltd total liabilities. Based on the latest financial reports, Eutilex.Co.Ltd (263050) has total liabilities worth ₩22.09 Billion KRW (≈ $14.97 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 263050 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Eutilex.Co.Ltd (2016–2024)

Total liabilities of Eutilex.Co.Ltd from 2016 to 2024. This chart illustrates how Eutilex.Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 263050 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Eutilex.Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Eutilex.Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Avensia publ AB ST:AVEN	Sweden	Skr155.11 Million
Texchem Resources Bhd KLSE:8702	Malaysia	RM588.32 Million
Lotus Eye Hospital and Institute Limited NSE:LOTUSEYE	India	Rs108.97 Million
Conduril - Engenharia S.A LS:CDU	Portugal	€157.89 Million
R.P.P. Infra Projects Limited NSE:RPPINFRA	India	Rs5.00 Billion
WITTED MEGACORP OYJ EO 1 F:8OS	Germany	€10.25 Million
KB Autosys Co. Ltd KQ:024120	Korea	₩125.72 Billion
N.D. Rubber Public Company Limited BK:NDR	Thailand	฿279.69 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Eutilex.Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Eutilex.Co.Ltd assets under control.

Liquidity & Leverage Metrics

Eutilex.Co.Ltd Total Liabilities Ratios Explained

Eutilex.Co.Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.65	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.83	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.43	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Eutilex.Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Eutilex.Co.Ltd (2016–2024)

The table below shows the annual total liabilities of Eutilex.Co.Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩26.57 Billion ≈ $18.01 Million	+116.66%
2023-12-31	₩12.26 Billion ≈ $8.31 Million	-26.62%
2022-12-31	₩16.71 Billion ≈ $11.33 Million	-63.11%
2021-12-31	₩45.31 Billion ≈ $30.70 Million	-3.64%
2020-12-31	₩47.02 Billion ≈ $31.87 Million	+256.70%
2019-12-31	₩13.18 Billion ≈ $8.93 Million	+74.17%
2018-12-31	₩7.57 Billion ≈ $5.13 Million	+2.88%
2017-12-31	₩7.36 Billion ≈ $4.99 Million	+29.42%
2016-12-31	₩5.68 Billion ≈ $3.85 Million	--

About Eutilex.Co.Ltd

KQ:263050 Korea Biotechnology

Market Cap

$23.94 Million

₩35.32 Billion KRW

Market Cap Rank

#24376 Global

#1741 in Korea

Share Price

₩959.00

Change (1 day)

+29.95%

52-Week Range

₩683.00 - ₩1480.00

All Time High

₩41553.86